Close

INCR.U and INCR-U Related Headlines

Go Back

Oct 17, 2023 05:05PM InterCure Ltd (INCR) Issues Update Regarding the Security Situation in Israel
Oct 17, 2023 05:04PM InterCure Provides an Update Regarding the Security Situation in Israel
Aug 31, 2023 07:45PM InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
Jul 10, 2023 05:00PM InterCure Ltd (INCR) Announces Proposed Voluntary Delisting from the Toronto Stock Exchange
Jul 10, 2023 05:00PM InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
Jun 9, 2023 05:18PM InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
May 15, 2023 05:59PM InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
May 15, 2023 05:45PM InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
May 15, 2023 08:30AM InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
Apr 25, 2023 07:19PM InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

INCR.U and INCR-U Related Press Releases

Go Back

Oct 17, 2023 05:04PM InterCure Provides an Update Regarding the Security Situation in Israel
Aug 31, 2023 07:45PM InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
Jul 10, 2023 05:00PM InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
Jun 9, 2023 05:18PM InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
May 15, 2023 05:59PM InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
May 15, 2023 05:45PM InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
May 15, 2023 08:30AM InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
Apr 25, 2023 07:19PM InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

INCR.U and INCR-U Related SEC Filings

Go Back